NRG Oncology trial: Hippocampal avoidance during whole-brain radiotherapy reduces risks

NRG Oncology trial: Hippocampal avoidance during whole-brain radiotherapy reduces risks

NRG Oncology trial: Hippocampal avoidance during whole-brain radiotherapy reduces risks

Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and pat